Express Pharma
Home  »  Archive  »  Leica Biosystems to acquire Aperio

Leica Biosystems to acquire Aperio

0 26
Read Article

Leica Biosystems announced that an affiliate has entered into a definitive agreement to acquire Aperio, a leading provider of ePathology solutions. Aperio will be integrated into Leica Biosystems, a leader in anatomical pathology solutions. Together, the two businesses will leverage each other’s strengths to grow and expand digital pathology into the global life science and healthcare markets.

The integrated business will provide industry leading solutions in each step of the anatomical pathology workflow, from sample preparation and staining, to imaging and reporting. The company will continue to offer both the Aperio and the existing Leica portfolio of Digital Pathology solutions, so that customers will enjoy more freedom to choose a solution that meets their individual needs.

“Together we offer the market an end-to-end solution from the time that the specimen is collected to the time that the results are delivered, to help our customers improve workflow efficiency and diagnostic confidence,” said Arnd Kaldowski, President, Leica Biosystems.

David Schlotterbeck, CEO, Aperio, said, “The combined product offerings and improved reach into the diagnostic market will make our ePathology Solutions more widely available.”

EP News Bureau

Leave A Reply

Your email address will not be published.

 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
Attend India's Largest Pharma Packaging & Labelling Conclave
Register Now